'Arterioscler thromb vasc biol' diaporamas de présentation

Pharmacologic Options in the Invasive Management of Acute Coronary Syndrome

Pharmacologic Options in the Invasive Management of Acute Coronary Syndrome. Ross J. Goodfellow , DO FACC FSCAI Health First Medical Group Cape Canaveral Hospital /Holmes Regional Medical Center Cocoa Beach & Melbourne, Florida. Disclosures. Speaker Astra Zeneca Zoll Medical.

996 views • 62 slides

Case #1

874 views • 47 slides

Case #1

579 views • 47 slides

Youth Obesity Causes, Consequences, and Solutions

585 views • 43 slides

Vulnerable Plaque

1.67k views • 36 slides

382 views • 25 slides

Lp-PLA 2 Lipoprotein-associated phospholipase A 2

Lp-PLA 2 Lipoprotein-associated phospholipase A 2. Closing the Diagnostic Gap in Cardiovascular Risk Assessment. The role of Lp-PLA 2 in risk assessment of cardiovascular disease. Hubert Scharnagl Clinical Institute of Medical and Chemical Laboratory Diagnostics

918 views • 24 slides

Pulmonary Embolism Treatment in Cancer - Is It Different

Pulmonary Embolism Treatment in Cancer - Is It Different. 34th Brazilian Thoracic Conference 6th ALAT Congress 5th Brazil-Portugal Congress Brazilia/DF November 22, 2008 Alvin V. Thomas, Jr., M.D., FACP, FCCP Immediate Past President ACCP

322 views • 21 slides

411 views • 17 slides

100 90 80 70

100 90 80 70. Fatal or non-fatal event-free time to coronary artery disease, stratified by baseline C-reactive protein quartiles. % survival. 0 5 10 15. Years.

111 views • 2 slides

INTRODUCTION

1500. 1500. 1000. 1000. 500. 500. 0. 0. INTRODUCTION. -500. -500. -1000. -1000.

53 views • 1 slides

Result

RANKL/OPG serum concentration ratio as a new biomarker for coronary artery calcification Amir Hooshang Mohammad pour 1 , Saeed Nazemi 2 , Mohammad Ramezani 3 , Samira Ghadirzadeh 3 , Shabnam Shahsavand 4 , Hayedeh Hashemizadeh 5 , Negar Milani Moghadam 4

180 views • 1 slides